Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Ra Medical Systems Inc (RMED)

Ra Medical Systems Inc (RMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,032
  • Shares Outstanding, K 1,090
  • Annual Sales, $ 20 K
  • Annual Income, $ -25,070 K
  • 60-Month Beta 1.04
  • Price/Sales 324.12
  • Price/Cash Flow N/A
  • Price/Book 0.43
Trade RMED with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -57.50
  • Growth Rate Est. (year over year) +1,837.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.44 +24.63%
on 10/03/22
11.14 -39.11%
on 09/12/22
-0.49 (-6.74%)
since 09/06/22
3-Month
5.44 +24.63%
on 10/03/22
19.25 -64.78%
on 07/07/22
-12.77 (-65.33%)
since 07/06/22
52-Week
5.44 +24.63%
on 10/03/22
176.50 -96.16%
on 10/11/21
-143.72 (-95.50%)
since 10/06/21

Most Recent Stories

More News
Catheter Precision Files a Method-of-Use U.S. Patent Application for its VIVO™ Technology

Catheter Precision, Inc. (“Catheter Precision”), a medical device company focused on cardiac electrophysiology, announces the filing of a new U.S. patent application for its VIVO ™ (View Into Ventricular...

RMED : 6.78 (+5.12%)
SHAREHOLDER ALERT: Weiss Law Reminds BTRS, RMED, CYBE, and LTRY Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

BTRS : 9.31 (+0.11%)
RMED : 6.78 (+5.12%)
CYBE : 53.77 (-0.04%)
LTRY : 0.2766 (-1.18%)
Catheter Precision’s VIVO™ Technology to be Featured in Three Presentations at the Global Society of Cardiac Robotic Navigation Annual Meeting

Catheter Precision, Inc. , a medical device and technology company focused on cardiac electrophysiology, announces that its lead product, VIVO™ (View Into Ventricular Onset), will be featured in presentations...

RMED : 6.78 (+5.12%)
Catheter Precision Names Fatih Ayoglu as Business Development Manager—EMEA

Catheter Precision, Inc. , a medical device and technology company focused on cardiac electrophysiology, announces the appointment of Fatih Ayoglu to the newly created position of Business Development...

RMED : 6.78 (+5.12%)
Which Medical Stock Is the Better Buy This Fall: RMED or ABT?

Amid the rising rate of chronic diseases worldwide, the need for medical diagnosis and treatment has significantly increased. Given the sound prospects of the healthcare industry, Abbott (ABT) and Ra Medical...

ABT : 102.45 (-0.90%)
RMED : 6.78 (+5.12%)
SHAREHOLDER ALERT: Weiss Law Reminds RMED, CYBE, LTRY, and TMX Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

RMED : 6.78 (+5.12%)
CYBE : 53.77 (-0.04%)
LTRY : 0.2766 (-1.18%)
TMX : 39.21 (-2.92%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBET, RMED, OCSL, SESN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SBET : 0.8600 (+1.16%)
RMED : 6.78 (+5.12%)
OCSL : 6.21 (-1.58%)
SESN : 0.5001 (+4.21%)
Ra Medical Systems Announces Results of its Special Meeting of Stockholders and a 1-for-50 Reverse Stock Split

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces that at its virtual Special Meeting of Stockholders held today, the Company’s stockholders approved all...

RMED : 6.78 (+5.12%)
MDT : 84.42 (-0.74%)
5 Penny Stocks to Sell Before They Hit Zero

With the Fed’s meeting hot on the heels of an estimate-beating inflation figure, the market has braced itself for an aggressive interest rate hike. This spells trouble for beaten-down penny stocks whose...

ASTR : 0.6199 (-1.23%)
AVCT : 2.45 (-5.41%)
GOVX : 1.1200 (+1.82%)
MULN : 0.3283 (-4.03%)
RMED : 6.78 (+5.12%)
SHAREHOLDER ALERT: Weiss Law Reminds RMED, CYBE, LTRY, and MSTR Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

RMED : 6.78 (+5.12%)
CYBE : 53.77 (-0.04%)
LTRY : 0.2766 (-1.18%)
MSTR : 241.67 (-0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ra Medical Systems, Inc. is a commercial-stage medical device company. It develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company's product pipeline consists of DABRA which is a minimally-invasive excimer laser and disposable catheter...

See More

Key Turning Points

3rd Resistance Point 7.42
2nd Resistance Point 7.17
1st Resistance Point 6.97
Last Price 6.78
1st Support Level 6.52
2nd Support Level 6.27
3rd Support Level 6.07

See More

52-Week High 176.50
Fibonacci 61.8% 111.16
Fibonacci 50% 90.97
Fibonacci 38.2% 70.78
Last Price 6.78
52-Week Low 5.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar